PubMed Health⌕ Search

Biomedical subjects

M Calvo

Publications and source records attributed to M Calvo.

129 records · Page 8Linked to original sources

Ten-year follow-up in pediatric patients with allergic bronchial asthma: evaluation of specific immunotherapy.

Specific immunotherapy as a treatment for bronchial asthma has been a controversial field. A collaborative study was designed in an attempt to further define the possible contribution of specific immunotherapy in a pediatric population. One hundred and sixty-six patients were treated with immunotherapy and 248 received no immunotherapy. The results were compared during 10 years of follow-up in both groups. There was a significant decrease in the number of acute crisis in the treated group (p < 0.05). However, no differences were seen in the number of hospital admissions or in the quality of life between the treated and untreated groups. The treated group required significantly fewer drugs (p < 0.05). Thus, it is probable that the untreated group shows the same clinical indexes as the treated group due to their increased use of medication. Specific immunotherapy represents an effective treatment that changes the natural course of allergic bronchial asthma in pediatric patients.

Airway Obstruction↗

Anaphylaxis inhibitory factor: clinical evaluation in pediatric patients.

A factor similar to that reported in mouse, capable of inhibiting the passive cutaneous anaphylactic reaction (PCA), has been demonstrated in human sera. The present study reports the laboratory and clinical evaluation of this factor in pediatric patients. A low percentage of the allergic patients (7.7%) showed the inhibitory factor and a positive skin test, while 70% of the nonallergic patients showed the inhibitory factor and a negative skin test. The absence of this factor showed a significant relationship with the presence of allergy (p < 0.001) and with a positive skin test (p < 0.01), although no relationship was observed with total plasma IgE levels (p > 0.05). Thus, it is concluded that PCA inhibitory factor modifies the expression of IgE without affecting its synthesis. The absence of this factor allows the expression of IgE in allergic patients with positive skin tests. The clinical implication demonstrated indicates that this may be a useful tool in the study of allergic patients.

Child, Preschool↗

Correlation between the clinical classification of bronchial asthma severity and the methacholine test in children.

The purpose of this study was to validate the Methacholine Bronchial Challenge Test in its different degrees and to compare them with the different clinical classifications of bronchial asthma. Fifty-four child asthmatic patients over 6 years of age from the Respiratory Outpatient Clinic at La Union Hospital (Chile) were submitted to the clinical classification of bronchial asthma and later to the Methacholine Bronchial Challenge Test, which classified the children as mildly, moderately or severely hyperreactive to the test. In mildly asthmatic children, the Methacholine Test showed both a high sensitivity (100%) and specificity (92.3%). In moderately asthmatic children, the sensitivity decreased to 84.5%, whilst the specificity was maintained (92.3%). In severely asthmatic children, however, the sensitivity decreased to 53.5%, whilst the specificity increased 97.2%. The latter could be explained as a consequence of the previous exposure of this group of children to either inhaled or oral corticoids. According to our experience, the Methacholine Test is not only useful for the diagnosis of bronchial hyperreactivity in dubious cases, but also for contributing together with the clinical findings to the adequate classification of these patients.

Asthma↗